p" In an attempt to facilitate the long-term proliferative growth and subsequent cloning of cytotoxic T lymphocytes (CTL's) against syngeneic murine 203-glioma (20-methylcholanthrene-induced ependymoblastoma of C57BL/6 mouse origin), sensitized T lymphocytes from tumor-beating mice were cultured in the presence of T cell growth factor (TCGF). Of five clones established by a limiting dilution technique, two clones (G-CTLL 1 and 2) exhibited tumor-specific cytotoxicity. G-CTLL 1 cells, which possessed much higher cytotoxic activity than G-CTLL 2 cells, were further analyzed. G-CTLL 1 cells were maintained in a TCGFdependent exponential proliferative culture for over 18 months and continued to mediate an extremely high cytotoxic activity with the target specificity (50-to 100-fold increases over the peak cytotoxic activity of sensitized T lymphocytes in tumor-beating mice). Their phenotypes of surface antigens were Thy-I + (weak positive), Lyt-1 _2.+3 § and asialo-GM~-, and their cytotoxicity was blocked by adding only anti-Lyt-2 monoclonal antibodies. These results indicated that the cloned cells originated from CTL's. The cloned cells were characterized by the production of immune interferon with the glioma antigen-stimulation, suggesting that the immune interferon could enhance the cytotoxic activity of the CTL clone at the site of a clone-target cell recognition event.
I
T has been demonstrated that immunologically reactive T lymphocytes can be multiplied in vitro by means of T cell growth factor (TCGF), 4'5'1~ and that this lymphokine is capable of actively enhancing the cytotoxicity of sensitized lymphoid cells in its presence. ~' 3'9 Activated T lymphocytes specific for tumorantigens have been studied as a potential approach to experimental anti-cancer immunotherapy.l ~.~3, 33 In this present report, we describe an adaptation of such a method which allows the generation and long-term culture of syngeneic murine malignant glioma-specific cytotoxic T lymphocyte (CTL) clone lines (G-CTLL's) by TCGF, and have investigated their immunological properties and characteristics in vitro.
Materials and Methods

Animals
Male C57BL/6 mice, 6 to 8 weeks old, were supplied from the Animal Center of Kyoto University for all experiments.
Tumor Cells
A panel of eight tumor cell lines was used for testing the specificity of cloned CTL line (G-CTLL). Four were carcinogen-induced tumor cell lines: 1) a 20-methylcholanthrene-induced ependymoblastoma of C57BL/6 mouse origin, 203-glioma: 2) a methylcholanthreneinduced fibrosarcoma of C57BL/6 mouse origin, YM-12; 3) a benzopyrene-induced thymoma of C57BL/6 mouse origin, EL4; 4) a methylcholanthrene-induced mastocytoma of DBA/2 mouse origin, P815. Two were virus-induced tumor cell lines: 5) a Schmitt-Ruppin Rous sarcoma virus-induced malignant glioma of C3H/He mouse origin, RSV-M; 6) a Moloney leukemia virus-induced T cell lymphoma of A/Sn mouse origin, YAC-1. Two were spontaneously occurring tumor cell lines: 7) a neuroblastoma of A/J Ax mouse origin, C-1300; and 8) a malignant melanoma of C57BL/6 mouse origin, B-16.
The five adherent tumor cell lines (203-glioma, YM-12, RSV-M, C-1300, and B-16) were maintained in
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Con A = concanavalin A CPE CTL E/T FCS G-CTLL LU mAb NK PBS TCGF VSV = cytopathic effect = cytotoxic T lymphocyte = effector:target cell = fetal calf serum = glioma-specific CTL clones = lytic unit = monoclonal antibodies = natural killer = phosphate-buffered saline = T cell growth factor = vesicular stomatitis virus tissue culture with Dulbecco's modified minimal essential medium supplemented with 10% heat-inactivated fetal calf serum (FCS) and antibiotics (penicillin G, 200 units/ml: streptomycin sulphate, 50 mg/ml). This culture medium is referred to as "Dulbecco's complete medium." The three non-adherent tumor cell lines (EL4, P815, and YAC-1) were maintained in tissue culture with RPMI-1640 medium, supplemented with 10% heat-inactivated FCS and the same antibiotics as the other cell lines. This culture medium is referred to as "RPMI complete medium." All of the tumor cell lines have been consistently free of Mycoplasma contamination.
In Vivo Immunization
The tumor cell suspensions of 203-glioma cells were prepared by trypsinizing monolayer tumor cells with 0.1% trypsin and 0.01% ethylenediaminetetraacetic acid (EDTA) in phosphate-buffered saline (PBS: contents, in gm/liter: NaCI, 8.0; Na2HPO4, 1.15; KC1, 0.2: and KH2PO4, 0.2, in distilled water) for 10 minutes. After the cells were washed three times with Dulbecco's complete medium at low-speed centrifugation, the cell concentration was adjusted to 5 x 105 cells/ml, and the cells were injected subcutaneously into the left flank of mice.
In the subcutaneously tumor-beating mice, the CTL activity of regional (inguinal and axillary) lymph-node cells began to increase 5 days after the tumor cell inoculation. A peak activity was observed on Day 14 and activity continued for over 4 weeks, but gradually declined as the tumor grew. 38
Preparation of TCGF
The TCGF was produced by a modification of the method of Gillis, et al. ~7 Briefly, Wistar rat spleen and mesenteric lymph-node cells were suspended at 5 x 106/ml in RPMI-1640 medium supplemented with 2% heat-inactivated FCS and 2 ug/ml concanavalin A (Con A). The suspension was cultured at 370C for 18 hours in a humidified atmosphere of 5% CO2. The crude culture supernatants were decanted twice every 18 hours, centrifuged at 10,000 rpm for 20 minutes and resterilized by Millipore filtration. Usually, 30% conditioned medium, containing 30% of these sterilized crude culture supernatants, is used for the maintenance of G-CTLL cells. This conditioned medium is referred to as "Con A-sup."
For the removal of Con A, the crude culture supernatants were concentrated by ammonium sulphate precipitation (40% to 80% saturation) and partially purified by ion-exchange chromatography (DEAE (diethylaminoethyl)-cellulose, elution with 50 mM in NaC1 at pH 7.4). These obtained supernatants are referred to as "TCGF."
Cloned CTL Line (G-CTLL)
The best conditions for the proliferation and longterm culture of G-CTLL cells are described as follows. On Day 14 after the subcutaneous inoculation of 203-glioma cells, 106/0.5 ml regional lymph node T cells were prepared and cultured with 5 x 104/0.5 ml antigen-presenting cells in flat-bottomed 24-well plates. The antigen-presenting cells were derived from the spleens of the tumor-bearing mice 6 weeks after the tumor-cell inoculation. These mice had received whole-body irradiation (850 rads) 2 days before culture. Two days later, 1 ml of 30% TCGF was added to the cultures and, another 3 days later, the cell cultures were transferred to other 24-well plates with additional 30% TCGF and antigen-presenting cells (2 x 105/ml). Three to 7 days later, three cell clusters that were cytotoxic against 203-glioma cells were obtained, separated, and fed every 3 days to maintain the long-term culture. These cells were referred to as "primary clone a, b, and c." Primary clone a cells, which exhibited the highest cytotoxicity of the three primary clones, were distributed at a limiting dilution of 0.3 cell/well in 100 ul volume with 30% Con A-sup. On Days 4 and 8 after distribution, 30% Con A-sup alone was added to the cultures in 100 ul volume. The subclones that presented single proliferating cell clusters were defined as "secondary monoclones." Five secondary monoclones grew progressively (referred to as "'G-CTLL cells"), and were transferred successively to flat-bottomed 24-well plates and 25-sq cm culture flasks in the presence of 30% Con A-sup, The G-CTLL cells were fed every 2 to 3 days and maintained by weekly subculture in 30% Con A-sup.
Cell SurJace Markers
The presence of cell surface antigens on G-CTLL cells was evaluated by antibody-dependent complement-mediated cytotoxicity assay using appropriate antibodies as follows. Anti-Thy-1~ anti-Lyt-1, and Lyt-2 monoclonal antibodies (mAb) against mouse T cell differentiation antigens: Thy-1, purified mAb (at 10 ug/ml); Lyt-1, purified mAb (at 20 ~g/ml); Lyt-2, purified (at 20 ug/ml). Rabbit anti-asialo-GMl antiserum against surface antigens of mouse natural killer (NK) cells freed of anti-BSA antibodies on a BSA-Affi-Gel 15 column (at a 1:100 dilution).
For the two-step cytotoxicity assay, an equal volume (1 ml aliquots) of diluted antibody (at a predetermined dilution which was known to lyse all cells expressing the particular specificity) and the cloned cells (106/ml) were incubated in RPMI complete medium at 4~ for 30 minutes. The cells were washed, and then 1 ml of complement (selected for high complement activity, but low toxicity for mouse cells) was added at a 1:10 dilution, and the mixture was incubated at 37~ for 45 minutes. After washing twice, the cells were resuspended in RPMI complete medium, and the cell viability was determined by the Trypan blue dye exclusion method.
Assay of T Cell-Mediated Cytotoxicity
The cell-mediated anti-tumor cytotoxic activity was estimated in triplicate by a modification of the method of Takasugi and Klein. 36 Briefly, 3 x 104/0.1 ml target cells treated with mitomycin C (50 ug/ml for 45 minutes) were incubated for 24 hours before the addition of effector cells. The mixtures of the effector and target cells at various effector:target cell (E/T) ratios were then incubated in a final volume of 0.2 ml in a flat-bottomed 96-well microtiter plate. After 18 hours of incubation at 37~ the target cell suspensions were prepared, and viable tumor cells were calculated by the Trypan blue dye exclusion method. The cytotoxic activity was expressed as follows: Cytotoxic activity (%) = (1 -surviving target cells obtained after incubation with effector cells/surviving target cells obtained after incubation with medium alone) x 100. 
Assay of Interferon Activity
Interferon activity was assessed in a conventional cytopathic effect (CPE) inhibition assay of vesicular stomatitis virus (VSV) on L cells? L cells were seeded into a 96-well microtiter plate in a volume of 100 ul/ well. To this was added 100 ~1 of serially diluted test supernatants. Twenty-four hours later, 100 ul of VSV was added to each well, and 48 hours after infection, the tissue monolayer was scored visually for virusinduced CPE after discarding the medium. The interferon titer is defined as the reciprocal of the highest dilution showing at least 50% inhibition of CPE in triplicate cultures. Titers were expressed in international reference units. The type of interferon was determined by the antibody neutralization test and the acid (pH 2.0)-stability test. 29 Antibody Neutralization Test. Rabbit anti-mouse immune or a/3-type interferon antisera were used. Briefly, each aliquot of diluted antiserum (1:30) was mixed with an equal volume of serially diluted test samples and incubated at room temperature for 1 hour. Then 50 ul of each sample was added to L cell monolayers and assayed for interferon activity.
Acid-Stability Test. One volume of the test samples was dialyzed for 24 hours at 4~ against 100 volumes of pH 2.0 buffer containing 0.1 M glycine-HCl and 0.15 M NaCI. Samples then underwent dialysis against PBS at pH 7.4 for another 24 hours. After dialysis, the samples were assayed for interferon activity. As a control, an identical sample of immune interferon was dialyzed against PBS at pH 7.4 for 48 hours. , and 400 after starting continuous culture, G-CTLL 1 cells were assessed for their cytotoxic activity against a panel of eight tumor cell lines. The cloned cells exhibited a strikingly high cytotoxic activity against syngeneic 203-glioma cells (t = P < 0.005) and a mild cytotoxic activity against allogeneic RSV-M glioma cells (r = p < 0.05). On the other hand, the cloned cells had no cytotoxic activity against a panel of another six non-glial tumor cell lines (YM-12, B-16 . ELA, YAC-I, P815, and C-1300). Accordingly, the cloned cells appeared to mediate a murine glioma-associated antigen-specific cytotoxicity. ND = not done; see also Definitions of Abbreviations.
Results
Establishment of Murine G-CTLL by TCGF
Five monoclonal G -C T L L cells were obtained from primary clone a (cloning efficiency was 5.2%). Of these five monoclones, two clones (G-CTLL 1 and 2) displayed a strikingly high cytotoxic activity against 203-glioma cells at a low E/T ratio (Table 1) . Since G -C T L L 1 cells exhibited a much higher cytotoxicity than G-CTLL 2 cells, the G -C T L L 1 cell line was selected as an established clone and was used for detailed study.
The proliferative growth of G -C T L L 1 cells was totally dependent on the presence of TCGF, demonstrating a doubling time of 24 to 36 hours. On Day 35 after starting continuous culture, they showed a strikingly high cytotoxic activity approximately 50 times greater than the peak cytotoxic activity in tumor-bearing mice (Fig. 1) . They have continuous steady proliferation and a high cytotoxic activity against the glioma cells for over 18 months. Upon thawing, frozen G-CTLL 1 cells were reestablished in a long-term TCGFdependent culture. Three to 4 weeks after reinitiation of continuous culture, the cloned cells have remained   FIG. 2 . Blocking of target cell lysis by anti-Lyt-2 monoclonal antibodies (mAb) in the absence of complement. Percent blocking of cytotoxicity by anti-Lyt-2 mAb is calculated as 100 • (I -% cytotoxicity in the presence of antibody/% cytotoxicity in the absence of antibody). Percent blocking is represented in the reciprocal dilution curve. in a proliferative status, totally dependent on the presence of TCGF, and their cytotoxic activity was retained with similar high levels. The ability of the cloned cells to recover from the cryopreserved state was confirmed. Table 2 shows that G -C T L L 1 cells appeared to be specific against murine glioma cells. The cloned cells exhibited a cross-reactive cytotoxic activity between syngeneic 203-glioma and allogeneic RSV-M glioma cell lines and revealed no significant cytotoxic activity against the other six non-glial tumor cell lines. According, the cytotoxic activity of G -C T L L 1 cells was probably against the murine glioma-associated antigen, and not against the mouse major histocompatibility complex.
Target Specificity of G-CTLL 1 Cells
Surface Markers of G-CTLL 1 Cells
On Day 35 after starting long-term culture, G -C T L L 1 cells were positive for Thy-1 and Lyt-2 antigens, but they exhibited phenotypes of neither Lyt-I nor asialo-GM~. Consequently, the surface markers of the cloned cells were Thy-1 § Lyt-l.72,+3 +, and asialo-GM~-. On Days 56 and 180, however, the surface markers were Thy-l-, Lyt-1.-2.+3 +, and asialo-GM~- (Table 3) . Furthermore, their cytotoxicity was consistently abolished by adding only anti-Lyt-2 mAb in the absence of complement (Fig. 2) . These results indicated that the cloned cells are derived from T-cells, not from N K cells, and that their essential role is to mediate a killer mechanism. 23 
Production of Immune Interferon by G-CTLL 1 Cells
The G -C T L L 1 cells released a small amount of interferon spontaneously (data not shown), and the interferon production was enhanced by stimulation with syngeneic 203-glioma and allogeneic RSV-M (Table 4 ). This result indicated that, like its cytotoxicity activity, the G-CTLL 1 cell line appeared to secrete interferon in response to the murine gliomaassociated antigen-specific stimulation. It was also found that interferon produced by G-CTLL 1 cells was of an immune type, based on the ability of antisera to immune-type interferon to neutralize its antiviral activity and on its sensitivity to pH 2.0 (Table 5) . 29
Discussion
The brain is generally known to be an immunologically privileged site, but the condition is partially lost when a tumor develops in the brain. As a result, the host's immune reactions to a new antigenic stimulus result in infiltration of lymphoid cells. 2'727 According to our previous experimental model, 38 the brain tumor-specific CTL's were found to be generated even in such immunologically incompetent circumstances as presented by an intracranial tumor-bearing host, and exhibited temporary but substantial anti-tumor effects. 38 Therefore, if a large number of the brain tumor-specific CTL cloned cells were obtained, the specific adoptive immunotherapy with the cloned cells could be much more effective than presently available nonspecific immunotherapy.
Recent advances in immunological techniques, particularly the use of TCGF, have made possible the longterm culture of homogeneous lines of lymphocytes with defined specificities. It is postulated that, as a second signal in the T cell immune response, TCGF stimulates T lymphocytes in the G~ phase of the cell cycle and functions to mediate the proliferative expansion of antigen-activated T lymphocyte clones. 32'37 Over the past 5 years, several groups have been successful in establishing lines and monoclonal cultures of specifically sensitized cytotoxic lymphoid cells of mouse and human origin. 4'5'10'15"16'22'26 '30'31"34 However, there has been no report on monoclonal CTL lines against brain tumors so far as we know. In this present study, we have described the establishment T. Yamasaki, et al.
TABLE 4 Production of immune interferon by G-CTLL 1 cells*
Interferon Activity Tumor Cell Line
Mouse (U/ml) Origin E/T = 0/1 E/T = 2/1 203-glioma C57BL/6 < 2 140t B-16 melanoma C57BL/6 < 2 33 YM-12 fibrosarcoma C57BL/6 < 2 10 EL4 thymoma C57BL/6 < 2 < 2 RSV-M glioma C3H/He < 2 156t C-1300 neuroblastoma A/J Ax < 2 4 P815 mastocytoma DBA/2J < 2 < 2 YAC-1 T cell lymphoma A/Sn < 2 32 *G-CTLL 1 cells were harvested 7 to 12 days after the previous subculture. After washing twice, the cells were cultured in RPM1 complete medium with various kinds of tumor cells for 24 hours at 37~ The culture supernatants were assayed for interferon activity. The cloned cells produced large amounts of interferon when cultured with syngeneic 203-glioma and allogeneic RSV-M glioma cells (t = P < 0.005). See Definitions of Abbreviations.
of syngeneic murine malignant glioma-specific CTL clone (G-CTLL 1) by TCGF and first investigated their immunobiological characteristics in vitro with a view to the future study of in vivo anti-tumor activity.
G-CTLL 1 cells have been strictly dependent for proliferative growth on TCGF, and continued to mediate an extremely high cytotoxic activity against 203-glioma cells for over 18 months. It is suggested that the cloned cells have possessed a target specificity for the murine glioma-associated antigen, because they exhibited a cross-reactivity between syngeneic 203-glioma and allogeneic RSV-M glioma cell lines and revealed no significant cytotoxicity against the other six nonglial tumor cell lines. On the other hand, it is unknown whether the cytotoxicity of the cloned cells may be against the viral antigens or not. If we had other tumor cell lines induced in mice by the same virus as RSV-M glioma or YAC-1 T cell lymphoma cell line, this problem could be ascertained. However, the cloned cells had no cytotoxicity against 1) other allogeneic tumor cell lines, such as P815 mastocytoma; 2) other syngeneic tumor cell lines, such as YM-12 fibrosarcoma and EL4 thymoma; and 3) other neuroectodermal tumor cell lines, such as C-1300 neuroblastoma and B-16 malignant melanoma. Therefore, it is thought that the cytotoxic activity of G-CTLL 1 cell line is directed only against the murine glioma-associated antigen.
The cytotoxic activity of G-CTLL 1 cell line was blocked by adding only anti-Lyt-2 mAb in the absence of complement. This result is compatible with a theory that suggests that Lyt-2 molecule is correlated with the nature of the antigenic determinant or the antigen recognition structure, and that this molecule may play an essential role in the differentiated function of CTL's. 23 Therefore, the cloned cells were confirmed to originate from CTL's.
It is generally known that immune interferon is pro- < 2I" *The type of interferon (IFN) produced by the cloned cells was determined by the antibody neutralization test and/or the acid-stability test. The IFN activity was abolished by the treatment with antiimmune IFN, and partially inactivated by the treatment with pH 2.0. Accordingly, G-CTLL l cell line appeared to produce immune IFN in response to the murine glioma-associated antigen-specific stimulation (t = P < 0.005; ~t = p < 0.01). See Definitions of Abbreviations.
duced by lymphoid cells during the course of an immune response. 6'24 In our experiment, it is noteworthy that G-CTLL 1 cells were able to produce immune interferon spontaneously and that the interferon production was enhanced by stimulation with the two kinds of glioma (203-glioma and RSV-M glioma) cells. Accordingly, this interferon production also seemed to be related to the murine glioma-associated antigen. The interferon production possibly contributes to the killing of target cells recognized by the cloned cells and the inhibition of the tumor growth, because the immune interferon can activate the killer mechanisms at the site of a CTL-target cell recognition event. 6 It is hoped that well characterized CTL clones such as the G-CTLL cell line might ultimately be of practical value in the immunotherapy of malignant human brain tumors. However, there are many unsolved problems associated with clinical application of the adoptive immunotherapy with CTL clones grown in TCGF in vitro.
These problems are as follows:
Abnormal Migration or Trapping of Cloned Cells" Injected Intravenously
Lotze, et al., 2~ showed that cultured murine and human lymphocytes were trapped in the lung early after intravenous injection and were subsequently redistributed to the liver and spleen. It has been proposed that the abnormal migratory properties of these lymphocyte clones are due to their loss of surface receptors for high endothelial venules that are necessary for normal lymphocyte migration, s'~2
Antigenic Modulation or Functioning Tumorigenesis of Cloned Cells
Takado, et al., 35 showed a functioning tumor of cloned CTL against a syngeneic tumor. This is one of the most troublesome problems.
Excessive TCGF-Dependeno' of Cloned Cells ' Mills, et al., 25 observed that iodine-125-1abeled tumor-specific cytotoxic lymphocytes adoptively transferred did not persist in significant numbers in vivo.
This suggests that their cytotoxic activity disappeared rapidly after the adoptive transfer intravenously, probably due to the rapid clearance of TCGF.
Production of Antibody Against Cloned Cells
Fathman and Kimono ~4 indicated that antibodies against CTL clones inhibited the in vivo efficacy.
Presence ~ff TCGF-Inhibitor in Serum
Hardt, et al., 18 demonstrated that an inhibitor, which is present in the sera of normal mice, inhibits the development of CTL in vivo.
Rapid Clearance of TCGF
Miihlradt and Opitz z8 reported that TCGF is only effective at the site of administration, because it is cleared from the body. This rapid clearance may prevent the systemic effects of TCGF.
Residual Lectin in TCGF Preparation
Lotze and Rosenberf ~ showed that very small amounts of residual lectin present in TCGF preparation may cause the activation and expansion of T lymphocytes in combination with other factors in the preparation. Therefore, Rosenstein, et al., 3~ indicated that the use of TCGF made free of lectin appears to be important in achieving the in vivo efficacy of CTL's grown in TCGF in vitro.
For these reasons, at present we believe that the specific adoptive immunotherapy of human brain tumors with TCGF-dependent CTL clones might be particularly useful in the local adoptive transfer into the postoperative tumor bed rather than through systemic administration.
